BeOne Medicines AG (ONC)
NASDAQ: ONC · Real-Time Price · USD
279.99
+4.65 (1.69%)
At close: Jun 26, 2026, 4:00 PM EDT
279.89
-0.10 (-0.04%)
After-hours: Jun 26, 2026, 4:10 PM EDT
BeOne Medicines AG Employees
BeOne Medicines AG had 12,000 employees as of December 31, 2025. The number of employees increased by 1,000 or 9.09% compared to the previous year.
Employees
12,000
Change (1Y)
1,000
Growth (1Y)
9.09%
Revenue / Employee
$475,411
Profits / Employee
$44,478
Market Cap
31.12B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,088 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
| Insmed | 1,664 |
| Ascendis Pharma | 1,189 |
ONC News
- 7 days ago - Baker Bros. Advisors LP's Strategic Acquisition of BeOne Medicines Ltd Shares - GuruFocus
- 14 days ago - BeOne Medicines' Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026 - Business Upturn
- 14 days ago - BeOne Medicines' Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026 - Business Wire
- 15 days ago - RSI Alert: BeOne Medicines (ONC) Now Oversold - Nasdaq
- 15 days ago - BeOne Medicines Presents Promising CLL Data for Patients Over 80 - GuruFocus
- 15 days ago - BeOne Medicines (ONC) Presents Encouraging Phase 3 Data on Brukinsa for CLL - GuruFocus
- 15 days ago - BeOne Medicines announces presentation of Phase 3 data in CLL patients - TheFly
- 15 days ago - BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit - Business Wire